Evidence map›Paper›PMID 25750210›Full record

ArticleEMBO molecular medicine2015

A streptococcal lipid toxin induces membrane permeabilization and pyroptosis leading to fetal injury.

Christopher Whidbey, Jay Vornhagen, Claire Gendrin, Erica Boldenow, Jenny Mae Samson, Kenji Doering, Lisa Ngo, Ejiofor A D Ezekwe, Jens H Gundlach, Michal A Elovitz and 4 more

Open access · goldAbstract read
In one paragraph

Article in EMBO molecular medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
10.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 83 citations in OpenAlex.

  1. Article
  2. Not all Group BFrontiers in cellular and infection microbiology · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Colonisation of Group BBMJ open · 2023
    Article
  8. Article
  9. Article
  10. Macrophage polarization duringFrontiers in microbiology · 2023
    Article
  11. Review
  12. Article
  13. Nitric Oxide Production and Effects in Group BPathogens (Basel, Switzerland) · 2022
    Article
  14. Mechanisms of group BReproduction & fertility · 2022
    Review
  15. Article
  16. Article
  17. Review
  18. MSC-ACE2 AmelioratesFrontiers in immunology · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Christopher WhidbeyDepartment of Pediatric Infectious Diseases, University of Washington and Seattle Children's Research Institute, Seattle, WA, USA Department of Global Health, University of Washington, Seattle, WA, USA.
Jay VornhagenDepartment of Pediatric Infectious Diseases, University of Washington and Seattle Children's Research Institute, Seattle, WA, USA Department of Global Health, University of Washington, Seattle, WA, USA.
Claire GendrinDepartment of Pediatric Infectious Diseases, University of Washington and Seattle Children's Research Institute, Seattle, WA, USA.
Erica BoldenowDepartment of Pediatric Infectious Diseases, University of Washington and Seattle Children's Research Institute, Seattle, WA, USA.
Jenny Mae SamsonDepartment of Physics, University of Washington, Seattle, WA, USA.
Kenji DoeringDepartment of Physics, University of Washington, Seattle, WA, USA.
Lisa NgoDepartment of Pediatric Infectious Diseases, University of Washington and Seattle Children's Research Institute, Seattle, WA, USA.
Ejiofor A D EzekweDepartment of Medicine, Division of Infectious Diseases and Pharmacology, School of Medicine and Lineberger Comprehensive Cancer Center University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Jens H GundlachDepartment of Physics, University of Washington, Seattle, WA, USA.
Michal A ElovitzMaternal and Child Health Research Program, Department of Obstetrics and Gynecology, Center for Research on Reproduction and Women's Health Perelman School of Medicine University of Pennsylvania, Philadelphia, PA, USA.
Denny LiggittDepartment of Comparative Medicine, School of Medicine University of Washington, Seattle, WA, USA.
Joseph A DuncanDepartment of Medicine, Division of Infectious Diseases and Pharmacology, School of Medicine and Lineberger Comprehensive Cancer Center University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Kristina M Adams WaldorfDepartment of Obstetrics and Gynecology, School of Medicine University of Washington, Seattle, WA, USA.
Lakshmi RajagopalDepartment of Pediatric Infectious Diseases, University of Washington and Seattle Children's Research Institute, Seattle, WA, USA Department of Global Health, University of Washington, Seattle, WA, USA lakshmi.rajagopal@seattlechildrens.org.
University of Washington · USSeattle Children's Hospital · USUniversity of North Carolina at Chapel Hill · USUniversity of Pennsylvania · US

Funding

ACADEMIC PEDIATRIC INFECTIOUS DISEASET32HD007233 · NICHD · SEATTLE CHILDREN'S HOSPITAL · PI KEVIN B URDAHL · 1985 to 2026
$6.7M
Diseases of Public Health Importance Training GrantT32AI007509 · NIAID · UNIVERSITY OF WASHINGTON · PI LUND, JENNIFER M · 1997 to 2024
$6.3M
UW Post-Baccalaureate Research Education Program (PREP)R25GM086304 · NIGMS · UNIVERSITY OF WASHINGTON · PI Gabriele Varani · 2011 to 2026
$5.7M
GBS mediated in utero fetal injuryR01AI100989 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI ADAMS WALDORF, KRISTINA M., RAJAGOPAL, LAKSHMI · 2012 to 2016
$3.9M
Regulation of the physiologic and pathologic activation of the NLRP3-inflammasomeR01AI088255 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DUNCAN, JOSEPH A · 2010 to 2020
$3.9M
Role of an ornithine rhamnolipid pigment in GBS virulenceR01AI112619 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI RAJAGOPAL, LAKSHMI · 2014 to 2018
$2.4M
Environmental Signals that regulate GBS virulenceR21AI109222 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI RAJAGOPAL, LAKSHMI · 2014 to 2015
$553k
Eukaryotic-signaling mediates two-component regulation of GBS virulenceR56AI070749 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI RAJAGOPAL, LAKSHMI · 2013 to 2013
$482k
NIAID NIH HHS R01 AI088255NIAID NIH HHS R01AI088255NIAID NIH HHS R01 AI100989NIAID NIH HHS R01AI100989NIAID NIH HHS R01 AI112619NIAID NIH HHS R01AI112619,NIAID NIH HHS R21 AI109222NIAID NIH HHS R21AI109222NIAID NIH HHS R56 AI070749NIAID NIH HHS R56AI070749,NIAID NIH HHS T32 AI007509NIAID NIH HHS T32 AI07509NICHD NIH HHS T32 HD007233NIGMS NIH HHS 5R25 GM086304NIGMS NIH HHS R25 GM086304
6 · The paper itself

Abstract

Group B streptococci (GBS) are Gram-positive bacteria that cause infections in utero and in newborns. We recently showed that the GBS pigment is hemolytic and increased pigment production promotes bacterial penetration of human placenta. However, mechanisms utilized by the hemolytic pigment to induce host cell lysis and the consequence on fetal injury are not known. Here, we show that the GBS pigment induces membrane permeability in artificial lipid bilayers and host cells. Membrane defects induced by the GBS pigment trigger K(+) efflux leading to osmotic lysis of red blood cells or pyroptosis in human macrophages. Macrophages lacking the NLRP3 inflammasome recovered from pigment-induced cell damage. In a murine model of in utero infection, hyperpigmented GBS strains induced fetal injury in both an NLRP3 inflammasome-dependent and NLRP3 inflammasome-independent manner. These results demonstrate that the dual mechanism of action of the bacterial pigment/lipid toxin leading to hemolysis or pyroptosis exacerbates fetal injury and suggest that preventing both activities of the hemolytic lipid is likely critical to reduce GBS fetal injury and preterm birth.

Indexed as

Bacterial ToxinsCell Membrane PermeabilityFetal DiseasesMembrane LipidsStreptococcal InfectionsStreptococcus agalactiaeAnimalsCell Line, TumorFemaleHumansMaleMiceMice, KnockoutPyroptosisBacterial ToxinsMembrane Lipidscell deathGroup B streptococcushemolytic pigmentinflammasomepreterm birth

Identifiers

PMID25750210
PMCPMC4403049
OpenAlexW2104436935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.